193 related articles for article (PubMed ID: 17240300)
1. Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas.
Albores-Saavedra J; Simpson K; Dancer YJ; Hruban R
Ann Diagn Pathol; 2007 Feb; 11(1):3-9. PubMed ID: 17240300
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
3. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
[TBL] [Abstract][Full Text] [Related]
4. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
7. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
[TBL] [Abstract][Full Text] [Related]
9. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
10. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
Fan Z; Li J; Dong B; Huang X
Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
[TBL] [Abstract][Full Text] [Related]
11. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.
Zhang MQ; Lin F; Hui P; Chen ZM; Ritter JH; Wang HL
Am J Clin Pathol; 2007 Nov; 128(5):808-16. PubMed ID: 17951204
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
Cathro HP; Mills SE
Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
14. Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature.
Kwon AY; Han J; Chu J; Choi YS; Jeong BH; Ahn MJ; Ahn YC
Pathol Res Pract; 2017 Feb; 213(2):106-112. PubMed ID: 28038793
[TBL] [Abstract][Full Text] [Related]
15. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Young RH; Hart WR
Am J Surg Pathol; 1998 Jul; 22(7):805-15. PubMed ID: 9669343
[TBL] [Abstract][Full Text] [Related]
16. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
Mizoshita T; Tsukamoto T; Inada KI; Hirano N; Tajika M; Nakamura T; Ban H; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
[TBL] [Abstract][Full Text] [Related]
17. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
Sanada Y; Kunita S; Yoshida K
Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
[TBL] [Abstract][Full Text] [Related]
18. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
20. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.
De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL
Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
